Stock listing

Munich:P0F Egetis Therapeutics AB Aktie

German listing (Munich) of Egetis Therapeutics AB · home listing Stockholm:EGTX

Follow Egetis Therapeutics AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:EGTX

9.77 SEK +0.52 (+5.6%)

Close on Oct 27, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:EGTX

Past year +74.8% · daily closes, Oct 27, 2025 – Oct 27, 2026, adjusted for splits
Day range
9.24 – 9.79 SEKOct 27, 2026
Volume
2.09M sharesOct 27, 2026
Market cap
4.54B SEKAt the close on Oct 27, 2026 · price × 465.0M shares outstanding
52-week range
3.63 – 10.14 SEKLowest and highest trades, Oct 28, 2025 – Oct 27, 2026
Egetis Therapeutics AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:EGTX · Home9.77 SEK+0.52 (+5.6%)2,094,6129.289.799.249.25Close on Oct 27, 2026
LSE:0ABW9.71 SEK+0.625 (+6.9%)22,1719.609.719.4459.085Close on Oct 27, 2026
Frankfurt:P0F€0.85 EUR+0.049 (+6.1%)—€0.802€0.85€0.802€0.801Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 27, 2026 – Oct 27, 2026 · OMXSTO:EGTX · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
9.77+0.52+5.6%9.289.799.242,094,612
9.25+0.19+2.1%9.119.349.081,229,759
9.06-0.18-1.9%9.229.228.961,510,430
9.24-0.33-3.4%9.469.509.201,196,900
9.57+0.40+4.4%9.189.579.101,016,605
9.17+0.10+1.1%9.029.269.001,607,727
9.07-0.17-1.8%9.269.369.002,075,949
9.24+0.03+0.3%9.219.459.211,075,660
9.21-0.24-2.5%9.509.539.112,099,877
9.45-0.15-1.6%9.639.689.302,183,842
9.60-0.35-3.5%9.9010.069.602,349,030
9.95+0.02+0.2%9.9210.109.801,980,498
9.93+0.08+0.8%9.9710.089.752,212,439
9.85+0.31+3.2%9.6610.149.454,254,187
9.54-0.02-0.2%9.359.789.254,158,483
9.56+0.50+5.5%9.159.619.134,008,629
9.06-0.12-1.3%9.189.388.953,737,929
9.18-0.26-2.8%9.459.689.146,060,584
9.44+0.58+6.5%8.889.478.819,704,484
8.86+0.43+5.1%8.549.108.448,160,852
8.43+0.99+13.3%8.479.098.2230,201,271
7.44-0.44-5.6%7.918.007.362,232,918
7.88+0.17+2.2%7.727.997.542,378,572
7.71-0.08-1.0%7.807.957.591,122,836
7.79-0.15-1.9%7.947.957.65659,437
7.94+0.34+4.5%7.647.967.60854,144
7.60-0.31-3.9%8.008.007.432,254,925
7.91-0.09-1.1%8.048.307.901,826,613
8.00+0.12+1.5%7.948.047.87508,682
7.88+0.01+0.1%7.927.957.80529,098
7.87-0.09-1.1%7.968.187.87689,813
7.96+0.07+0.9%8.008.047.89524,614
7.89-0.16-2.0%8.078.107.87505,531
8.05-0.01-0.1%8.008.207.951,173,584
8.06+0.07+0.9%7.988.067.90811,835
7.99+0.34+4.4%7.557.997.55919,513
7.65-0.05-0.6%7.737.827.50717,128
7.70-0.14-1.8%7.907.977.62636,574
7.84+0.07+0.9%7.828.057.82567,811
7.77-0.12-1.5%7.908.067.75558,715
7.89+0.04+0.5%7.868.047.71957,098
7.85-0.15-1.9%8.088.207.851,012,317
8.00-0.04-0.5%8.038.147.94904,285
8.04+0.04+0.5%7.958.047.451,143,835
8.00+0.13+1.7%7.868.157.731,317,378
7.87+0.36+4.8%7.497.877.451,437,262
7.51+0.18+2.5%7.357.647.201,225,791
7.33+0.53+7.8%6.967.376.961,515,701
6.80-0.14-2.0%7.007.006.73574,661
6.94-0.08-1.1%7.007.156.91580,491
7.02-0.07-1.0%7.037.126.91512,294
7.09-0.07-1.0%7.207.207.01433,837
7.16-0.08-1.1%7.197.287.00661,887
7.24+0.01+0.1%7.157.357.12499,041
7.23+0.29+4.2%6.947.266.92695,576
6.94-0.05-0.7%7.067.076.93340,386
6.99-0.09-1.3%7.087.146.731,121,387
7.08+0.23+3.4%6.847.216.841,256,588
6.85+0.11+1.6%6.846.946.67731,610
6.74+0.36+5.6%6.496.906.39803,369
6.38+0.27+4.4%6.196.536.08844,845
6.11+0.11+1.8%6.076.325.861,827,310
6.00-0.11-1.8%6.116.285.991,362,958
6.11-0.15-2.4%6.256.256.01601,757
6.26-0.32-4.9%6.586.606.22586,322
6.58-0.14-2.1%6.736.736.56261,578
6.720.000.0%6.836.836.62304,162
Ticker
Munich:P0F
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Munich
Currency
EUR

What changed lately

Calls

Replays

  • Egetis Therapeutics (Stockholm:EGTX) Q2 2026 Earnings Call

    Fri, Aug 21, 2026 · 8:00 AM ET

    Watch Transcript

  • Egetis Therapeutics (Stockholm:EGTX) Q1 2026 Earnings Call

    Wed, Apr 29, 2026 · 4:00 AM ET

    Watch Transcript

Latest news

Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE(R) (tiratricol) for Patients with MCT8 Deficiency

Sep 29, 2026

Closed 8.43 (+13.3%) on Sep 29, 2026

Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency

Sep 28, 2026

Closed 8.43 (+13.3%) on Sep 29, 2026

Egetis Therapeutics to Participate in Upcoming Investor Conferences in September

Sep 3, 2026

Closed 7.84 (+0.9%) on Sep 3, 2026

Egetis' Interim report Q2 2026

Aug 21, 2026

Closed 7.33 (+7.8%) on Aug 21, 2026

Invitation to Presentation of Egetis’ Q2 2026 Report on August 21, 2026

Aug 7, 2026

Closed 7.08 (+3.4%) on Aug 7, 2026

Change in the number of shares and votes in Egetis Therapeutics

May 29, 2026

Closed 6.08 (+0.8%) on May 29, 2026

Exercise of options under employee stock option program and notification of insider trading

May 13, 2026

Closed 6.77 (+0.3%) on May 15, 2026

Egetis Announces Grant of Patent for MCT8 Deficiency Composition in The U.S.

May 5, 2026

Closed 6.46 (+6.4%) on May 5, 2026

Interim ReportQ12026

May 3, 2026

Closed 6.07 (+8.2%) on May 4, 2026

Invitation to Presentation of Egetis’ First Quarter 2026 Report on April 29, 2026

Apr 24, 2026

Closed 5.84 (-1.2%) on Apr 24, 2026

All Egetis Therapeutics AB news

Decks

Egetis Therapeutics AB on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
18 in the last 12 months · 18 in all · newest Sep 29, 2026 · oldest 2026
Calls
2 calls with a replay · 2 with a transcript · latest Aug 21, 2026
Decks
18 decks · latest October 2026

Where Egetis Therapeutics AB is listed

ListingExchangeCountryCurrency
Stockholm:EGTX · Home listingStockholmSwedenSEK
LSE:0ABWLSEUnited KingdomSEK
OTC:PDPHFOTCUnited StatesUSD
Lang & Schwarz:A1JH3BLang & SchwarzGermanyEUR
LS Exchange:A1JH3BLS ExchangeGermanyEUR
Frankfurt:P0FFrankfurtGermanyEUR
Aquis:EGTXSAquisUnited KingdomSEK
gettex:P0FgettexGermanyEUR
Aquis:EGTXSAquisUnited KingdomSEK
Munich:P0F · This pageMunichGermanyEUR
Stuttgart:P0FStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Egetis Therapeutics AB.